To all those who said Ellume would go their own way and not use anteotech this is a nice big F-U from the CEO. key takeaways- "for the supply of AnteoBind to be used in Ellume’s range of tests"
This will be used in future tests not just covid test
"We look forward to supporting Ellume to achieve their ambition of a large volume of test sales in the US market in 2022 and beyond."
We know revenue thus far has been low but volume of tests they have supplied this year has also been very low, ramp up begins from now.
"The terms of the contract are commercial-in-confidence and reflect the commercial positions of both companies having undergone significant transformation over the past five years."
No mention of expected revenue which leaves us guessing but this above states it reflects current position of both companies whereas previous agreement both were infants.
lets hope this kicks off news flow into the new year.
ADO Price at posting:
20.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)